Cellular Code Cracked: How Biotech Is Rewriting the Future of Aging

Biotech companies are translating cellular reprogramming from laboratory research to clinical reality, with the potential to treat not just age-related diseases like glaucoma but aging itself. Simultaneously, interoception research is unveiling how the body's internal signaling networks govern everything from metabolic regulation to emotional health. These convergent breakthroughs signal a fundamental shift in how technology will reshape human biology.